Traction
Real Numbers. Real Market.
Avant Labs has moved from platform development into active market validation — with product in market, samples distributed, and a growing pipeline of licensing and co-formulation partners.
50,000+
Strips Sold
Buccal thin-film units to date
Thousands
Marketing Samples Distributed
Across brand and creator programs
4+
Product Lines in Market
Across both delivery platforms
4
Patent Applications Filed
Covering both platforms
Milestone Timeline
From Platform to Market
2023
Platform R&D Initiated
Buccal thin-film and topical carrier formulation research begins. Core carrier chemistry and film matrix development underway.
2024 Q1
First Formulations Validated
Initial buccal thin-film formulations validated for stability and dissolution performance. Topical carrier compositions confirmed.
2024 Q3
Patent Applications Filed
First patent applications filed covering topical carrier compositions.
2024 Q4
First Product Lines Launched
4+ product lines brought to market across both platforms. Initial direct-to-consumer and brand partnership channels activated.
2025
50,000+ Strips Sold
Avant Labs has validated its underlying oral thin-film platform with more than 50,000 white-label strips sold and is now scaling a dedicated consumer brand.
2026
Seed Round Open
Seed financing round opened to institutional and strategic investors. Capital to accelerate licensing pipeline, expand IP portfolio, and scale manufacturing.
In Progress2026–2027
Licensing Pipeline Activation
Structured licensing agreements with established brands across nutraceutical, cosmeceutical, and recovery verticals.
Pipeline
What's in Market. What's Coming.
Thin-Film Nutraceutical Line
Multiple SKUs in active distribution
Creator Co-Formulation Program
Samples distributed, LOIs in progress
Topical Hand Cream Protectant
Persistent topical hand cream formulations in distribution
Cosmeceutical Licensing Program
Partner formulations in development
Exclusive Vertical Licensing
Exclusivity by vertical available to qualified partners
See the Full Picture
Detailed traction data, pipeline metrics, and financial projections are available in the investor materials.